ArticleNature reviews. Gastroenterology & hepatology2021

Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD.

Katrina RayPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.